Strs Ohio Next Cure, Inc. Transaction History

Strs Ohio

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$9.47 - $12.43 $59,661 - $78,309	-6,300 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$21.19 - $40.2 $10,595 - $20,100	500 Added 8.62%	6,300 $135,000
Q3 2019 Oct 21, 2019	BUY	$15.73 - $41.6 $78,650 - $208,000	5,000 Added 625.0%	5,800 $178,000
Q2 2019 Jul 25, 2019	BUY	$14.16 - $20.64 $11,328 - $16,512	800 New	800 $11,000

14.6M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $17.2M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.